Cargando…

Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients: A single-center registry study

OBJECTIVES: The primary aim was to investigate the efficacy and safety of dual antiplatelet therapy (DAPT) using ticagrelor (T-DAPT) versus clopidogrel (C-DAPT) in a real-world ST-elevation myocardial infarction (STEMI) population. METHODS: We retrospectively analyzed 655 consecutive patients having...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hee, Leia, Gibbs, Oliver J., Assad, Joseph G., Sharma, Lokesh D., Hopkins, Andrew, Juergens, Craig P., Lo, Sidney, Mussap, Christian J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599087/ https://www.ncbi.nlm.nih.gov/pubmed/31296977 http://dx.doi.org/10.1016/j.jsha.2019.05.005

Ejemplares similares

The Impact of COVID-19 on ST Elevation Myocardial Infarction
por: Femia, G., et al.
Publicado: (2021)

Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST‐Segment–Elevation Myocardial Infarctions
por: Schmucker, Johannes, et al.
Publicado: (2019)

Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan
por: Lee, Chih-Kuo, et al.
Publicado: (2021)

Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction
por: Welsh, Robert C., et al.
Publicado: (2021)

Utility of prehospital electrocardiogram interpretation in ST‐segment elevation myocardial infarction utilizing computer interpretation and transmission for interventional cardiologist consultation
por: Faour, Amir, et al.
Publicado: (2022)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
por: Volney, Candice, et al.
Publicado: (2019)

Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis
por: Vercellino, Matteo, et al.
Publicado: (2017)

Bleeding complications with clopidogrel or ticagrelor in ST-elevation myocardial infarction patients – A real life cohort study of two treatment strategies()
por: Alfredsson, Joakim, et al.
Publicado: (2020)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
por: Scanavini-Filho, Marco Antonio, et al.
Publicado: (2022)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
por: Peasah, Samuel K., et al.
Publicado: (2023)

Comparative study of ticagrelor and clopidogrel in therapeutic effect of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Yao, Guangtao, et al.
Publicado: (2017)

Comparison of the Infarct Size between the Loading of Ticagrelor and Clopidogrel in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Yun, Kyeong Ho, et al.
Publicado: (2017)

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
por: Tjerkaski, Jonathan, et al.
Publicado: (2023)

Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention
por: Kim, Yuri, et al.
Publicado: (2023)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
por: YANG, Bin, et al.
Publicado: (2018)

Short-term efficacy of ticagrelor in acute ST-segment elevation myocardial infarction patients undergoing an emergency percutaneous coronary intervention
por: Cao, Bangming, et al.
Publicado: (2019)

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
por: Samman, Karla N., et al.
Publicado: (2021)

Safety and feasibility of low‐dose ticagrelor in patients with ST‐segment elevation myocardial infarction
por: Wang, Yanbo, et al.
Publicado: (2020)

Varying Definitions for Periprocedural Myocardial Infarction Alter Event Rates and Prognostic Implications
por: Idris, Hanan, et al.
Publicado: (2014)

Comparison of the influence of ticagrelor and clopidogrel on inflammatory biomarkers and vascular endothelial function for patients with ST-segment elevation myocardial infarction receiving emergency percutaneous coronary intervention: study protocol for a randomized controlled trial
por: Li, Zhenhua, et al.
Publicado: (2016)

Effect of preoperative loading dose ticagrelor and clopidogrel on no-reflow phenomenon during intervention in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis
por: Dai, Weiran, et al.
Publicado: (2018)

Pulmonary Alveolar Hemorrhage after Clopidogrel Use for ST Elevation Myocardial Infarction
por: Kim, Youngjoong, et al.
Publicado: (2013)

Late Outcomes of Patients With Prehospital ST‐Segment Elevation and Appropriate Cardiac Catheterization Laboratory Nonactivation
por: Faour, Amir, et al.
Publicado: (2022)

Long‐Term Ticagrelor Versus Prasugrel Pharmacodynamics in Patients With ST‐Segment–Elevation Myocardial Infarction
por: Cassese, Salvatore, et al.
Publicado: (2020)

No Differences in Levels of Circulating Progenitor Endothelial Cells or Circulating Endothelial Cells Among Patients Treated With Ticagrelor Compared With Clopidogrel During Non–ST‐Segment–Elevation Myocardial Infarction
por: Diego‐Nieto, Alejandro, et al.
Publicado: (2018)

Cost-effectiveness of clopidogrel vs. ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome
por: van den Broek, Wout W A, et al.
Publicado: (2022)

Small-Vessel Vasculitis After ST-Segment Elevation Myocardial Infarction: Clopidogrel or Amiodarone?
por: Lehr, Saskia, et al.
Publicado: (2022)

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study
por: Adamski, Piotr, et al.
Publicado: (2017)

Incidence and predictors of left ventricular thrombus formation following acute ST-segment elevation myocardial infarction: A serial cardiac MRI study()
por: Phan, Justin, et al.
Publicado: (2019)

Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel
por: Gasecka, Aleksandra, et al.
Publicado: (2020)

Hospitalization for Myocardial Infarction with Ticagrelor or Clopidogrel in Patients with Acute Coronary Syndrome: An On-Treatment Comparative Effectiveness Analysis
por: Olufade, Tope, et al.
Publicado: (2021)

Safety of Bivalirudin Combined with Ticagrelor in the Emergency PCI in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Wang, Zheng-Dong, et al.
Publicado: (2022)

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial
por: Lindholm, Daniel, et al.
Publicado: (2014)

Ticagrelor as an Alternative for Clopidogrel-Associated Acute Arthritis
por: Bedy, Starr-Mar'ee C., et al.
Publicado: (2018)

A Comparative Pharmacodynamic Study of Ticagrelor versus Clopidogrel and Ticagrelor in Patients Undergoing Primary Percutaneous Coronary Intervention: The CAPITAL RELOAD Study
por: Hibbert, Benjamin, et al.
Publicado: (2014)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2019)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
por: Zheng, Wei, et al.
Publicado: (2019)

Sex Differences in Outcome and Prescribing Practice in ST-elevation MI Patients with Multivessel Disease and Incomplete Revascularisation
por: Burgess, Sonya, et al.
Publicado: (2023)

Ticagrelor vs. Clopidogrel in Older Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From a Real-World Registry
por: Zhang, Yunnan, et al.
Publicado: (2022)

Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)
por: Tran, Huyen, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_4d9htmjena4fchn1sfkdgp7su9